Paraneoplastic syndromes
著者
書誌事項
Paraneoplastic syndromes
(Contemporary neurology series, 79)
Oxford University Press, c2011
- : hardcover
大学図書館所蔵 全4件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Paraneoplastic syndromes, defined in this book as "disorders caused by cancer, but not a direct result of cancer invasion of the affected organ or tissue", once believed to be rare and esoteric neurologic disorders have assumed increasing importance as an explanation of neurologic and other symptoms in patients suffered from occult or controllable cancers. This book attempts a comprehensive review of paraneoplastic syndromes from considering both clinical and
pathophysiologic aspects. The book is divided into 4 sections: The first is an overview, classifying the disorders, describing a clinical approach to the diagnosis and treatment of paraneoplastic syndromes in general and identifying their pathogenesis. The second section discusses the clinical findings
and treatment of individual paraneoplastic syndromes with chapters dedicated to each of the neurologic syndromes and a chapter discussing nonneurologic syndromes such as endocrine, cutaneous, and rheumatologic paraneoplastic disorders. The third section discusses autoantibodies that characterize individual paraneoplastic syndromes. The final section discusses the paraneoplastic syndromes associated with individual cancers.
目次
- Contents
- SECTION 1 OVERVIEW
- 1. HISTORY
- DEFINITIONS
- CLASSIFICATION
- HISTORY
- Pathogenesis
- EPIDEMIOLOGY
- IMPORTANCE
- 2. CLINICAL FINDINGS, TREATMENT AND PROGNOSIS
- INTRODUCTION
- CLINICAL APPROACH
- The Patient without Known Cancer The Patient with Known Cancer
- CLUES TO DIAGNOSIS
- Clinical Findings Laboratory Investigation
- PATHOLOGY
- TREATMENT
- Plasma Exchange (Plasmapheresis) Intravenous Immunoglobulin
- Rituximab Cyclophosphamide Corticosteroids Human Chorionic Gonadotropin Recommendations
- PROGNOSIS
- 3. PATHOGENESIS
- INTRODUCTION
- HISTORICAL VIEWS
- Toxic Substances Competition for Essential Substrate Bullet Opportunistic Infection Immune Mediated
- CURRENT CONCEPTS OF PATHOGENESIS
- Unresolved Questions Conclusions
- ANIMAL MODELS
- SECTION 2 CLINICAL SYNDROMES
- 4. BRAIN (CEREBRUM)
- INTRODUCTION
- CEREBRAL CORTEX
- WHITE MATTER DEMYELINATION
- BLOOD VESSELS (VASCULITIS)
- HIPPOCAMPUS/LYMBIC ENCEPHALITIS
- TASTE
「Nielsen BookData」 より